|
A more recent version of this article appeared on January 13, 2006
Papers In Press, published online ahead of print November 10, 2005
J. Biol. Chem, 10.1074/jbc.M506164200
Submitted on June 6, 2005
Revised on November 9, 2005
Accepted on November 10, 2005
Gerstmann-Straussler-Scheinker disease amyloid protein polymerizes according to the "dock-and-lock" model
Marco Gobbi, Laura Colombo, Michela Morbin, Giulia Mazzoleni, Elena Accardo, Marco Vanoni, Elena Del Favero, Laura Cantù, Daniel A. Kirschner, Claudia Manzoni, Marten Beeg, Paolo Ceci, Paolo Ubezio, Gianluigi Forloni, Fabrizio Tagliavini, and Mario Salmona
Biochemistry and Molecular Pharmacology, Istituto Mario Negri, Milan 20157
Corresponding Author: Gobbi{at}marionegri.it
Prion protein (PrP) amyloid formation is a central feature of genetic and acquired prion diseases such as Gerstmann-Sträussler-Scheinker disease (GSS) and variant CJD. The major component of GSS amyloid is a PrP fragment spanning residues ~82-146 which, when synthesized as a peptide, readily forms fibrils featuring GSS amyloid. The present study employed surface plasmon resonance (SPR) to characterize the binding events underlying PrP82-146 oligomerization at the first stages of fibrillization, according to evidence suggesting a pathogenic role of prefibrillar oligomers rather than mature amyloid fibrils. We followed in real-time the binding reactions occurring during short-term (sec) addition of PrP82-146 small oligomers (1-5mers, flowing species) onto soluble prefibrillar PrP82-146 aggregates immobilized on the sensor surface. SPR data confirmed very efficient aggregation/elongation, consistent with the hypothesis of nucleation-dependent polymerization process. Much lower binding was observed when PrP82-146 flowed onto the scrambled sequence of PrP82-146 or onto prefibrillar A 42 aggregates. As previously found with A 40, SPR data could be adequately fitted by equations modelling the dock-and-lock mechanism, in which the locking step is due to sequential conformational changes, each increasing the monomers affinity for the fibril until to condition of irreversible binding is reached. However, these conformational changes (i.e., the locking steps) appear to be faster and easier with PrP82-146 than with A 40. Such differences suggest that PrP82-146 has a greater propensity to polymerize and greater stability of the aggregates.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
L. Fioriti, N. Angeretti, L. Colombo, A. De Luigi, A. Colombo, C. Manzoni, M. Morbin, F. Tagliavini, M. Salmona, R. Chiesa, et al.
Neurotoxic and Gliotrophic Activity of a Synthetic Peptide Homologous to Gerstmann-Straussler-Scheinker Disease Amyloid Protein
J. Neurosci.,
February 14, 2007;
27(7):
1576 - 1583.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|